Health IT Trends for 2019

Jan 30, 2019

Electronic Health Reporter

“As we’ve seen in the past, it can sometimes be challenging for organizations to separate the hype from the hope when it comes to AI. Looking towards 2019, we can expect a continued embrace of AI technologies and a deeper understanding of them, along with further exploration into augmented reality, biometrics, automation, and health IT legislation. Continued shifts to alleviate the burdens on clinicians and healthcare professionals will also be in focus, making use of machine learning technologies in the clinical workflow with an emphasis on secure data sharing via the cloud to gain actionable insights and achieve improved health outcomes.”

 

The article “Health IT Trends for 2019” from Electronic Health Reporter discusses key technological advancements in healthcare, with a focus on FDNA’s Face2Gene technology. Face2Gene harnesses the power of artificial intelligence to analyze facial features and identify genetic disorders with high accuracy. This breakthrough allows healthcare providers to expedite the diagnosis of complex conditions swiftly, often before traditional methods can. The article highlights how such innovations in health IT are revolutionizing personalized medicine, improving patient outcomes, and streamlining clinical workflows.

 

Related articles

AI in genetic diagnosis

The Evolution of FDNA’s technology: An Interview with Aviram Bar Haim

Analyzing facial features has long been a vital step in diagnosing genetic syndromes. In recent years, AI-driven technologies have transformed this process, making it more efficient and accurate. Leading this innovation is Face2Gene, an advanced AI platform that leverages machine learning to assist clinicians in identifying genetic disorders. To explore the development of this groundbreaking […]

Continue reading
Genetic Research in Africa: An Interview

Genetic Research in Africa: An Interview with Dr. Aime Lumaka

Dr. Aime Lumaka, a distinguished geneticist from the Democratic Republic of Congo, is at the forefront of advancing genetic research across Africa. As a pivotal figure in the Deciphering Developmental Disorders in Africa (DDD-Africa) initiative and the Principal Investigator of the African Rare Diseases Initiative (ARDI), Dr Lumaka is leading efforts to evaluate clinical exome sequencing in […]

Continue reading